Lexeo Therapeutics, Inc. (LXEO) Capital Leases (2022 - 2023)
Lexeo Therapeutics' Capital Leases history spans 2 years, with the latest figure at $1.4 million for Q3 2023.
- For Q3 2023, Capital Leases changed N/A year-over-year to $1.4 million; the TTM value through Sep 2023 reached $1.4 million, changed N/A, while the annual FY2022 figure was $1.6 million, N/A changed from the prior year.
- Capital Leases for Q3 2023 was $1.4 million at Lexeo Therapeutics, down from $1.6 million in the prior quarter.
- Across five years, Capital Leases topped out at $1.6 million in Q4 2022 and bottomed at $1.4 million in Q3 2023.